Natus Medical Incorporated (BABY) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC lowered its stake in shares of Natus Medical Incorporated (NASDAQ:BABY) by 4.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 440,067 shares of the medical equipment provider’s stock after selling 19,530 shares during the period. Rice Hall James & Associates LLC owned 1.35% of Natus Medical worth $16,503,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Eqis Capital Management Inc. increased its stake in shares of Natus Medical by 25.0% during the 3rd quarter. Eqis Capital Management Inc. now owns 16,740 shares of the medical equipment provider’s stock worth $628,000 after purchasing an additional 3,353 shares during the last quarter. BlackRock Inc. increased its stake in shares of Natus Medical by 137,510.8% during the 1st quarter. BlackRock Inc. now owns 4,124,195 shares of the medical equipment provider’s stock worth $161,874,000 after purchasing an additional 4,121,198 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of Natus Medical by 9.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 973,346 shares of the medical equipment provider’s stock worth $36,307,000 after purchasing an additional 86,192 shares during the last quarter. Virginia Retirement Systems ET AL increased its stake in shares of Natus Medical by 122.3% during the 2nd quarter. Virginia Retirement Systems ET AL now owns 26,900 shares of the medical equipment provider’s stock worth $1,003,000 after purchasing an additional 14,800 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan increased its stake in shares of Natus Medical by 3.2% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 7,760 shares of the medical equipment provider’s stock worth $289,000 after purchasing an additional 240 shares during the last quarter. Institutional investors own 94.44% of the company’s stock.

In related news, Director Robert A. Gunst sold 4,400 shares of the stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $35.17, for a total transaction of $154,748.00. Following the transaction, the director now owns 50,850 shares in the company, valued at $1,788,394.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director William M. Moore sold 3,000 shares of the stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $34.10, for a total transaction of $102,300.00. Following the transaction, the director now owns 30,410 shares in the company, valued at approximately $1,036,981. The disclosure for this sale can be found here. 5.50% of the stock is owned by corporate insiders.

Several equities research analysts have recently issued reports on the stock. Zacks Investment Research upgraded shares of Natus Medical from a “hold” rating to a “buy” rating and set a $45.00 price target for the company in a research note on Tuesday, October 24th. BidaskClub lowered shares of Natus Medical from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 24th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $46.50.

ILLEGAL ACTIVITY NOTICE: “Natus Medical Incorporated (BABY) Shares Sold by Rice Hall James & Associates LLC” was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another website, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this article can be viewed at https://sportsperspectives.com/2017/11/02/natus-medical-incorporated-baby-shares-sold-by-rice-hall-james-associates-llc.html.

Natus Medical (NASDAQ:BABY) last issued its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $0.40 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.02. The company had revenue of $122.60 million for the quarter, compared to the consensus estimate of $122.41 million. Natus Medical had a negative net margin of 0.62% and a positive return on equity of 12.06%. The firm’s revenue for the quarter was up 34.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.39 earnings per share.

Natus Medical Company Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Want to see what other hedge funds are holding BABY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natus Medical Incorporated (NASDAQ:BABY).

Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply